EKG
BRASH Syndrome
search
BRASH Syndrome
, Bradycardia Syndrome with Renal Failure, AV Block, Shock and Hyperkalemia
See Also
Symptomatic Bradycardia
Hyperkalemia
Acute Renal Failure
Definitions
BRASH Syndrome
Bradycardia Syndrome with Renal Failure, AV Block, Shock and Hyperkalemia
Findings
BRASH Syndrome
Bradycardia
Renal Failure
AV Node Block
er (e.g.
Beta Blocker
or
Calcium Channel Blocker
)
Shock
(out of proportion to degree of
Hyperkalemia
, requires fluid
Resuscitation
and possible pressors)
Hyperkalemia
Pathophysiology
Occurs in patients with both
Hyperkalemia
AND on AV nodal blocking agents (e.g.
Beta Blocker
or
Calcium Channel Blocker
)
Profound
Bradycardia
, resulting in hypoperfusion and shock, and ultimately
Renal Failure
Other medications have been associated with BRASH
Amiodarone
ACE Inhibitor
s and
Angiotensin Receptor Blocker
s with
SGLT2 Inhibitor
s
Nagamine (2022) CJEM 24(1): 99-100 [PubMed]
Precautions
Key to treating BRASH Syndrome is recognizing the need for multifactorial management
Even mild
Hyperkalemia
may worsen
Bradycardia
in those already on
Beta Blocker
s
Management
Initiate
Hyperkalemia Management
See
Hyperkalemia Management
Initiate IV
Calcium
, IV
Insulin
and Dextrose
Consider Isotonic Bicarbonate infusion with 3 ampules bicarbonate in 1 liter of D5W and give 1-2 Liters
Use only if patient with acidosis and do not exceed bicarbonate deficit (risk of alkalosis)
Consider
Kaliuresis
in End-Stage Renal Disease patients needing
Dialysis
(but not yet on
Dialysis
), but is delayed
High dose
Diuretic
s are given (e.g. lasix 180 IV and 1000 mg
Chlorothiazide
IV and 500 mg IV
Acetazolamide
)
These doses are extremely high and require close monitoring of
Urine Output
Not typically effective in patients already on
Dialysis
Bradycardia
See
Unstable Bradycardia
May improve with IV
Calcium
and other
Acute Hyperkalemia Management
Consider
Epinephrine
infusion for
Bradycardia
and
Hypotension
Dehydration
Perform adequate fluid
Resuscitation
Hold or discontinue associated medications
Stop
Beta Blocker
s
Stop
Calcium Channel Blocker
Stop
ACE Inhibitor
s and
Angiotensin Receptor Blocker
s
References
Swaminathan and Farkas in Herbert (2019) EM:Rap 19(11): 11-2
Shah (2022) Eur J Intern Med 103: 57-61 +PMID: 35676108 [PubMed]
Type your search phrase here